Cellular Immune Responses in Triple-negative Breast Cancer - High Throughput Immunogenetic Studies
Clinical trial NCT06646263 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT06646263
- Sponsor
- Institute of Applied Biosciences
- Status
- ENROLLING_BY_INVITATION
- Study type
- OBSERVATIONAL
- Start date
- 2024-03-01
- Primary completion
- 2027-04-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.